Skip to main content

Showing results for Diabetes

Scientists call on professional community to support women in diabetes research

A group of leading scientists is holding a mirror to the diabetes research community and calling for the improved support of its female constituents. Linda DiMeglio, MD, MPH, of Indiana University School of Medicine and Mark Atkinson, PhD, of the University of Florida, led a deep dive into the historical representation of women in the diabetes research community and that of women in influential positions among four major diabetes organizations. 

IU School of Medicine  |  Jul 20, 2021

An evolutionary cul-de-sac: Study suggests most humans are vulnerable to Type 2 diabetes

Scientists have found that insulin has met an evolutionary cul-de-sac, limiting its ability to adapt to obesity and thereby rendering most people vulnerable to Type 2 diabetes. A recent study from scientists at Indiana University School of Medicine, the University of Michigan and Case Western Reserve University has determined that the sequence of insulin has become entrenched at the edge of impaired production, an intrinsic vulnerability unmasked by rare mutations in the insulin gene causing diabetes in childhood

IU School of Medicine  |  Nov 02, 2020

IU researchers in nationwide network to study rare form of diabetes

Indiana University School of Medicine researchers are participating in the Rare and Atypical Diabetes Network (RADIANT), a nationwide study funded by the National Institutes of Health. The study seeks to discover new forms of diabetes, identify their causes, and understand how they differ from more common types of diabetes.

IU School of Medicine  |  Oct 06, 2020

IU School of Medicine leading national study to treat diabetic foot wounds, decrease amputation rates

Indiana University School of Medicine is leading the first study of the national Diabetic Foot Consortium with the goal of preventing reopening of closed wounds by identifying a biomarker that would predict such recurrence during the process of standard wound care.

IU School of Medicine  |  Jul 24, 2020

Diabetes center recognizes scientists for promising projects

The Center for Diabetes and Metabolic Diseases (CDMD) at Indiana University School of Medicine has recognized six Indiana scientists for their innovative projects.

IU School of Medicine  |  Jun 18, 2020

Evans-Molina named director of diabetes research center

INDIANAPOLIS—Carmella Evans-Molina, MD, PhD, has been appointed director of the Center for Diabetes and Metabolic Diseases (CDMD) at Indiana University School of Medicine. Evans-Molina is the center’s second appointed director since it received designation from the National Institutes of Health in 2015. The center’s mission is to bring cutting-edge research tools to diabetes investigators at […]

IU School of Medicine  |  Oct 08, 2019

Funding to help researchers study link between high blood sugar, cancer

It is well understood that people with diabetes have an increased risk for a number of other health complications—including cancer. Last year, when Indiana University School of Medicine researchers demonstrated that inflammation can increase risk for leukemia, they wondered if it was also the culprit that placed people with diabetes at a higher risk for […]

IU School of Medicine  |  Jun 14, 2019

Study based at Indiana University School of Medicine finds improvements in insulin production wane after treatment stops in adults with early type 2 diabetes

A set of clinical trials examining youth and adults with type 2 diabetes or impaired glucose tolerance has found that disease progression in adults slowed during medical treatment but resumed after treatment stopped. Youth on the same treatment had markedly poorer outcomes with continued disease progression both during and after the treatment. This research, funded […]

Christina Griffiths  |  Jun 10, 2019

Immunotherapy delays Type 1 diabetes diagnosis in people at high risk

Presented on June 9 in San Francisco at the 2019 American Diabetes Association’s 79th Scientific Sessions and published in the New England Journal of Medicine, findings from TrialNet’s Teplizumab (anti-CD3) Prevention Study show a drug that targets the immune system can delay Type 1 diabetes a median of 2 years in children and adults at […]

IU School of Medicine  |  Jun 09, 2019

IU announces progress toward its Precision Health Grand Challenge: cancers it aims to cure, diseases it is working to prevent

Indiana University researchers and physicians announced progress toward their bold goals of developing cures and preventive treatments for devastating diseases prevalent among Indiana residents.

IU School of Medicine  |  Aug 06, 2018